ZNTL
Zentalis Pharmaceuticals, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$2.55
$-0.27
(-9.57%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $165.11M | EPS (ttm) | $-2.08 | Current Price | $2.55 |
| Enterprise Value | $-56.00M | Forward EPS | $-1.81 | Previous Close | $2.82 |
| P/E Ratio | - | ROA | -24.51% | 52W High | $3.95 |
| Forward P/E | -1.41 | ROE | -49.18% | 52W Low | $1.01 |
| PEG Ratio | - | Gross Margin | 100.00% | 50 Day Avg | $1.99 |
| P/S Ratio | 6.15 | Operating Margin | -567.77% | 200 Day Avg | $1.58 |
| P/B Ratio | 0.73 | Profit Margin | - | Volume | 757.37K |
| EV/EBITDA | 0.37 | Current Ratio | 7.76 | Avg Volume | 1.33M |
| EV/Sales | -2.08 | Quick Ratio | 7.55 | Beta | 1.72 |
| Employees | 166.00 | Debt/Equity | 16.00 | Shares Outstanding | 64.75M |
| Sector | Healthcare | Total Debt | $40.46M | Float Shares | 50.50M |
| Industry | Biotechnology | Total Cash | $280.70M | Short Float | 9.58% |
| Optionable | - | Cash/Share | $3.88 | Short Ratio | 1.87 |
| Dividend Yield | - | Book Value/Share | $3.50 | % Held by Insiders | 22.46% |
| Target Price | $5.31 | Revenue (TTM) | $26.86M | % Held by Institutions | 59.17% |